株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

欧州諸国 (全28ヶ国) の核酸検査 (NAT) 市場:売上高の予測とサプライヤー別市場シェア -- 感染症・遺伝子疾患・がん検査、法医学的検査、父子鑑定 -- 競争戦略、検査機器・技術レビュー、市場機会

2017 European Nucleic Acid Testing (NAT) Market in 28 Countries: Sales Forecasts and Supplier Shares--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

発行 Venture Planning Group 商品コード 352906
出版日 ページ情報 英文 1120 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。

Local License: 同一事業所内

Back to Top
欧州諸国 (全28ヶ国) の核酸検査 (NAT) 市場:売上高の予測とサプライヤー別市場シェア -- 感染症・遺伝子疾患・がん検査、法医学的検査、父子鑑定 -- 競争戦略、検査機器・技術レビュー、市場機会 2017 European Nucleic Acid Testing (NAT) Market in 28 Countries: Sales Forecasts and Supplier Shares--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
出版日: ページ情報: 英文 1120 Pages
概要

当レポートでは、欧州諸国 (計28ヶ国) における核酸 (NAT) 検査の市場について分析し、現在の技術開発・普及状況や、主要な検査装置のレビュー、各種検査の件数および試薬の売上高の見通し、主要サプライヤーのプロファイル・市場シェア、各国市場の詳細動向、今後の市場機会と克服すべき課題、各社が取るべき戦略などについて調査・考察しております。

第1章 イントロダクション

第2章 製品開発の主な機会

  • 検査装置
  • 試薬キット、検査システム/パネル
  • コンピューター、ソフトウェア、自動化
  • 補助製品

第3章 分散検査製品の設計基準

第4章 代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散検査市場の流通戦略

第5章 潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

第6章 世界の市場・技術の分析

  • DNAシーケンシング
  • DNA・RNAプローブ技術
  • 検出技術
  • 分子診断装置のレビュー (全25社分)
  • バイオチップ:遺伝子センサー・マイクロアレイ・ラブオンチップ
  • 薬理ゲノミクス
  • 主な用途
    • 微生物/感染症検査
    • がん検査
    • 遺伝子疾患
    • 法医学的検査
    • 父子鑑定/HLA型判定
    • その他の用途
  • 競合・補足技術

第7章 国別分析:市場規模・売上高の予測 -- 感染症、遺伝子疾患、がん、法医学的検査、父子鑑定

  • オーストリア
  • ベルギー
  • ブルガリア
  • チェコ
  • デンマーク
  • エストニア
  • フィンランド
  • フランス
  • ドイツ
  • ギリシャ
  • ハンガリー
  • アイスランド
  • アイルランド
  • イタリア
  • ラトビア
  • リトアニア
  • マルタ
  • オランダ
  • ノルウェー
  • ポーランド
  • ポルトガル
  • ルーマニア
  • スロバキア
  • スロベニア
  • スペイン
  • スウェーデン
  • スイス
  • 英国

第8章 競合企業の分析

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode Genetics
  • Diadexus
  • 栄研化学
  • Elitech Group
  • Enzo
  • Exact Sciences
  • 富士レビオ
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Monogram Biosciences/LabCorp
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • 島津製作所
  • Siemens
  • Sierra Molecular
  • タカラバイオ
  • Tecan Group

第9章 付録:革新的な分子診断技術・製品の開発に従事している主な大学・研究機関

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPNAT21486

This new 28-country survey from VPGMarketResearch.com contains over 1,150 pages, 213 tables, and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

- Supplier sales and market shares in major countries

- Five-year test volume and sales forecasts

- Strategic profiles of market players and start-up firms developing innovative technologies and products

- Emerging technologies

- Review of molecular diagnostic analyzers

- Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK

Market Segmentation Analysis

- Sales and market shares of key suppliers of molecular diagnostic reagent kits and components in major markets.

- Five-year test volume and sales forecasts for major applications, including:

&nbsp &nbsp - Infectious Diseases        &nbsp &nbsp - Forensic Testing
&nbsp &nbsp - Cancer&nbsp               &nbsp                  &nbsp - Paternity Testing/HLA Typing
&nbsp &nbsp - Genetic Diseases             &nbsp &nbsp - Others

- Five-year test volume and sales projections for over 30 NAT assays.

- Analysis of the sequencing market, including:

- Industrial Academic Government Commercial

- Market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.

Product/Technology Review

- Comparison of leading molecular diagnostic ;analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:

- PCR     - bDNA
- SDA     - NASBA
- TMA    - SSSR, and others
- LCR

- Universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

- Companies developing and marketing molecular diagnostics products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 1,150 pages and 213 tables

Table of Contents

I. Introduction

II. Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets

V. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VI. Worldwide Market and Technology Review

  • A. DNA Sequencing
    • 1. Introduction
    • 2. Sequencing Methods
    • 3. Autoradiography
    • 4. The Human Genome Project
    • 5. Sequencing Automation
    • 6. Image Scanners
    • 7. Fluorescent Detection
    • 8. Gene Profiling
    • 9. Gene Expression
    • 10. Polymorphism Screening
    • 11. Protein Interaction Networks
  • B. DNA and RNA Probe Technologies
    • 1. Basic Principles
    • 2. Probe Preparation
    • 3. The DNA Probe Test
    • 4. Test Formats
    • 5. Labeling Techniques
    • 6. Amplification Methods
  • C. Detection Technologies
    • 1. Radioactive Methods
      • a. Overview
      • b. Major Isotopes
    • 2. Non-Isotopic Methods
      • a. Enzymatic Labels
      • b. Chemical Labeling
      • c. Fluorescence
      • d. Chemiluminescence
      • e. Electrical Conductivity
  • D. Molecular Diagnostic Instrumentation Review
    • 1. Abbott LCx
    • 2. Beckman Coulter/Biomek FK
    • 3. BD Viper System with XTR Technology
    • 4. BD Innova
    • 5. Becton Dickinson SDA
    • 6. bioMerieux NucliSENS easyMAG
    • 7. bioMerieux NucliSENS easyQ and MiniMAG
    • 8. Bio-Rad GeneScope
    • 9. Cepheid GeneXpert
    • 10. Curetis Unyvero
    • 11. GenMark Dx eSensor XT-8
    • 12. Hologic/Gen-Probe Panther
    • 13. Hologic/Gen-Probe Tigris/DTS
    • 14. HTG Molecular Edge
    • 15. Life Technologies QuantStudio Dx
    • 16. Qiagen QIAsymphony RGQ
    • 17. Roche Cobas Amplicor
    • 18. Roche Cobas TaqMan 48
    • 19. Roche Cobas TaqMan
    • 20. Roche Cobas TaqMan AmpliPrep
    • 21. Roche LighCycler 480
    • 22. Roche Cobas 4800
    • 23. Roche Cobas s 201
    • 24. Siemens Versant
    • 25. Tecan LS Series
  • E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
    • Liquid Transportation and Mixing
    • Separation
    • Reaction
    • Detection
  • F. Pharmacogenomics
  • G. Major Applications
    • 1. Microbiology/Infectious Diseases
      • a. Overview
      • b. Major Infectious Diseases
        • AIDS/HIV
        • Adenovirus
        • Aeromonads
        • Anthrax/Bacillus Anthracis
        • Arboviruses
        • Babesiosis
        • Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
        • Blastocystis Hominis
        • Brucella
        • Campylobacter
        • Candida
        • Chagas Disease
        • Chancroid
        • Chlamydia
        • Clostridium Difficile
        • Coronaviruses
        • Coxsackieviruses
        • Creutzfeldt-Jakob's Disease
        • Cryptosporidium Parvum
        • Cyclospora Cayetanensis
        • Cytomegalovirus
        • Ebola Virus
        • E. Coli
        • Echovirus
        • Encephalitis
        • Enteroviruses
        • Epstein-Barr Virus
        • Giardia Lamblia
        • Gonorrhea
        • Granuloma Inguinale
        • Hantavirus
        • Helicobacter Pylori
        • Hepatitis
        • Herpes Simplex Virus
        • Human Herpes Virus-6 (HHV-6)
        • Influenza Viruses
        • Legionella
        • Lyme Disease
        • Lymphogranuloma Venereum (LGV)
        • Malaria
        • Measles (Rubeola)
        • Meningitis
        • Microsporidium
        • Mononucleosis
        • Mumps
        • Mycoplasma
        • Papillomaviruses
        • Parvovirus B19
        • Pneumonia
        • Polyomaviruses
        • Pseudomonas Aeruginosa
        • Rabies
        • Respiratory Syncytial Virus (RSV)
        • Rhinoviruses
        • Rotavirus
        • Rubella
        • Salmonellosis
        • Septicemia
        • Shigellosis
        • Staphylococcus Aureus
        • Streptococci
        • Syphilis
        • Toxoplasmosis
        • Trichomonas Vaginalis
        • Tuberculosis
        • Vibrio
        • West Nile Virus
        • Yersinia
    • 2. Cancer Testing
      • a. Overview
      • b. Major Cancer Types
        • Prostate
        • Lung
        • Colon and Rectum
        • Breast
        • Skin
        • Uterine
        • Leukemia
        • Oral
      • c. Oncogenes
        • Abl/abl-bcr
        • AIB1
        • BCL-2
        • BRCA1
        • CD44
        • C-fos
        • C-myb
        • C-myc
        • CYP17
        • Erb-B
        • HPC1
        • N-myc
        • P40
        • P51
        • P53
        • PIK3CA
        • PTI-1
        • Ras
        • Reg
        • Sis
        • Src
    • 3. Genetic Diseases
      • a. Overview
      • b. Nucleic Acid Amplification
      • c. Chromosome Imaging
      • d. Genomics Technologies
      • e. Proteomics Technologies
      • f. Current Pharmacogenomic Tests
      • g. Future Pharmacogenomic Testing
      • h. Major Diseases
        • Achondroplasia
        • Autosomal Dominant Polycystic Kidney Disease
        • Cancer
        • Cosmetogenomics
        • Cystic Fibrosis
        • Down's Syndrome
        • Duchenne and Becker Muscular Dystrophy
        • Factor V (Leiden)
        • Factor IX Deficiency
        • Fragile X Syndrome
        • Heart Disease
        • Hemochomatosis
        • Hemophilia
        • Huntington's Disease
        • Maternal-Fetal Incompatibility
        • Multiple Endocrine Neoplasia
        • Phenylketonuria (PKU)
        • Polycystic Kidney Disease (PKD)
        • Prenatal Screening
        • Retinitis Pigmentosa
        • Retinoblastoma
        • Sickle Cell Anemia
        • Spinal Muscular Atrophy
        • Vitamin B12 Metabolism
      • i. Social Issues and Concerns
    • 4. Forensic Testing
      • a. Overview
      • b. Multilocus and Single Locus Probes
      • c. DNA Profile Data Banks
      • d. Judicial Implementation
      • e. Major Crime Categories
      • f. Factors Contributing to the DNA Probe Market Expansion
        • Technology Availability
        • Use of Hair as Evidence
      • g. Wildlife Forensics
    • 5. Paternity Testing/HLA Typing
    • 6. Other Applications
      • a. Disease Susceptibility Testing
      • b. Cardiovascular Diseases
      • c. Diabetes
      • d. Alzheimer's Disease
      • e. Periodontal Disease
      • f. Plasma Purification
      • g. Organ Transplantation
      • h. Water Contamination
      • i. Other
  • H. Competing/complementing
    • 1. Monoclonal Antibodies/Immunoassays
    • 2. RNA Probes
    • 3. Two-Dimensional Electrophoresis
    • 4. Flow Cytometry

VII. Country Analyses: Volume and Sales Forecasts--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

  • Austria
  • Belgium
  • Bulgaria
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • UK

VIII. Competitive Assessments

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Eiken
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Monogram Biosciences/LabCorp
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

IX. Appendix: Major Universities and Research Centers Developing Innovative Molecular Diagnostic Technologies and Products

List of Tables

  • Austria
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Austria
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Austria
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Austria
  • Molecular Diagnostics Market Forecasts by Application
  • Austria
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Belgium
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Belgium
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Belgium
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Belgium
  • Molecular Diagnostics Market Forecasts by Application
  • Belgium
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Bulgaria
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Bulgaria
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Bulgaria
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Bulgaria
  • Molecular Diagnostics Market Forecasts by Application
  • Bulgaria
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Czech Republic
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Czech Republic
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Czech Republic
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Czech Republic
  • Molecular Diagnostics Market Forecasts by Application
  • Czech Republic
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Denmark
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Denmark
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Denmark
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Denmark
  • Molecular Diagnostics Market Forecasts by Application
  • Denmark
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Estonia
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Estonia
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Estonia
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Estonia
  • Molecular Diagnostics Market Forecasts by Application
  • Estonia
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Finland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Finland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Finland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Finland
  • Molecular Diagnostics Market Forecasts by Application
  • Finland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • France
  • Molecular Diagnostics Test Volume and Sales by Major Application
  • France
  • Laboratories Performing DNA Sequencing by Market Segment
  • France
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • France
  • Molecular Diagnostics Test Volume by Major Application
  • France
  • Major Infectious Disease Test Volume by Assay
  • France
  • Major Infectious Disease Test Volume by Method
  • France
  • Molecular Diagnostics Market by Major Application
  • France
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • France
  • Major Infectious Disease Diagnostics Market by Assay
  • France
  • AIDS Testing Market Estimated Sales by Major Supplier
  • France
  • Adenovirus Testing Market Estimated Sales by Major Supplier
  • France
  • Chlamydia Testing Market Estimated Sales by Major Supplier
  • France
  • CMV Testing Market Estimated Sales by Major Supplier
  • France
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • France
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • France
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • France
  • HIV/Hepatitis Blood Screening
  • NAT Market Reagent Sales by Major Supplier
  • France
  • Herpes Testing Market Estimated Sales by Major Supplier
  • France
  • Influenza Testing Market Estimated Sales by Major Supplier
  • France
  • Meningitis Testing Market Estimated Sales by Major Supplier
  • France
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • France
  • RSV Testing Market Estimated Sales by Major Supplier
  • France
  • Shigella Testing Market Estimated Sales by Major Supplier
  • Germany
  • Molecular Diagnostics
  • Test Volume and Sales by Major Application
  • Germany
  • Laboratories Performing DNA Sequencing by Market Segment
  • Germany
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • Germany
  • Molecular Diagnostics Test Volume by Major Application
  • Germany
  • Major Infectious Disease Test Volume by Assay
  • Germany
  • Major Infectious Disease Test Volume by Method
  • Germany
  • Molecular Diagnostics Market by Major Application
  • Germany
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • Germany
  • Major Infectious Disease Diagnostics Market by Assay
  • Germany
  • AIDS Testing Market Estimated Sales by Major Supplier
  • Germany
  • CMV Testing Market Estimated Sales by Major Supplier
  • Germany
  • EBV Testing Market Estimated Sales by Major Supplier
  • Germany
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Germany
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • Germany
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Germany
  • HIV/Hepatitis Blood Screening
  • NAT Market Reagent Sales by Major Supplier
  • Germany
  • Herpes Testing Market Estimated Sales by Major Supplier
  • Germany
  • Influenza Testing Market Estimated Sales by Major Supplier
  • Germany
  • Meningitis Testing Market Estimated Sales by Major Supplier
  • Germany
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • Germany
  • Pneumonia Testing Market Estimated Sales by Major Supplier
  • Germany
  • RSV Testing Market Estimated Sales by Major Supplier
  • Germany
  • Rotavirus Testing Market Estimated Sales by Major Supplier
  • Greece
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Greece
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Greece
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Greece
  • Molecular Diagnostics Market Forecasts by Application
  • Greece
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Hungary
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Hungary
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Hungary
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Hungary
  • Molecular Diagnostics Market Forecasts by Application
  • Hungary
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Iceland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Iceland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Iceland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Iceland
  • Molecular Diagnostics Market Forecasts by Application
  • Iceland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Ireland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Ireland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Ireland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Ireland
  • Molecular Diagnostics Market Forecasts by Application
  • Ireland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Italy
  • Molecular Diagnostics Test Volume and Sales by Major Application
  • Italy
  • Laboratories Performing DNA Sequencing by Market Segment
  • Italy
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • Italy
  • Molecular Diagnostics Test Volume by Major Application
  • Italy
  • Major Infectious Disease Test Volume by Assay
  • Italy
  • Major Infectious Disease Test Volume by Method
  • Italy
  • Molecular Diagnostics Market by Major Application
  • Italy
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • Italy
  • Major Infectious Disease Diagnostics Market by Assay
  • Italy
  • AIDS Testing Market Estimated Sales by Major Supplier
  • Italy
  • CMV Testing Market Estimated Sales by Major Supplier
  • Italy
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Italy
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • Italy
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Italy
  • HIV/Hepatitis Blood Screening
  • NAT Market Reagent Sales by Major Supplier
  • Italy
  • Herpes Testing Market Estimated Sales by Major Supplier
  • Italy
  • Influenza Testing Market Estimated Sales by Major Supplier
  • Italy
  • Meningitis Testing Market Estimated Sales by Major Supplier
  • Italy
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • Italy
  • RSV Testing Market Estimated Sales by Major Supplier
  • Latvia
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Latvia
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Latvia
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Latvia
  • Molecular Diagnostics Market Forecasts by Application
  • Latvia
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Lithuania
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Lithuania
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Lithuania
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Lithuania
  • Molecular Diagnostics Market Forecasts by Application
  • Lithuania
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Malta
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Malta
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Malta
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Malta
  • Molecular Diagnostics Market Forecasts by Application
  • Malta
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Netherlands
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Netherlands
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Netherlands
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Netherlands
  • Molecular Diagnostics Market Forecasts by Application
  • Netherlands
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Norway
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Norway
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Norway
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Norway
  • Molecular Diagnostics Market Forecasts by Application
  • Norway
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Poland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Poland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Poland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Poland
  • Molecular Diagnostics Market Forecasts by Application
  • Poland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Portugal
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Portugal
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Portugal
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Portugal
  • Molecular Diagnostics Market Forecasts by Application
  • Portugal
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Romania
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Romania
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Romania
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Romania
  • Molecular Diagnostics Market Forecasts by Application
  • Romania
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Slovakia
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Slovakia
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Slovakia
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Slovakia
  • Molecular Diagnostics Market Forecasts by Application
  • Slovakia
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Slovenia
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Slovenia
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Slovenia
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Slovenia
  • Molecular Diagnostics Market Forecasts by Application
  • Slovenia
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Spain
  • Molecular Diagnostics Test Volume and Sales by Major Application
  • Spain
  • Laboratories Performing DNA Sequencing by Market Segment
  • Spain
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • Spain
  • Molecular Diagnostics Test Volume by Major Application
  • Spain
  • Major Infectious Disease Test Volume by Assay
  • Spain
  • Major Infectious Disease Test Volume by Method
  • Spain
  • Molecular Diagnostics Market by Major Application
  • Spain
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • Spain
  • Major Infectious Disease Diagnostics Market by Assay
  • Spain
  • AIDS Testing Market Estimated Sales by Major Supplier
  • Spain
  • Chlamydia Testing Market Estimated Sales by Major Supplier
  • Spain
  • CMV Testing Market Estimated Sales by Major Supplier
  • Spain
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Spain
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • Spain
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Spain
  • HIV/Hepatitis Blood Screening
  • NAT Market Reagent Sales by Major Supplier
  • Spain
  • Herpes Testing Market Estimated Sales by Major Supplier
  • Spain
  • Influenza Testing Market Estimated Sales by Major Supplier
  • Spain
  • Meningitis Testing Market Estimated Sales by Major Supplier
  • Spain
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • Sweden
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Sweden
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Sweden
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Sweden
  • Molecular Diagnostics Market Forecasts by Application
  • Sweden
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Switzerland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Switzerland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Switzerland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Switzerland
  • Molecular Diagnostics Market Forecasts by Application
  • Switzerland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • U.K.
  • Molecular Diagnostics Test Volume and Sales by Major Application
  • U.K.
  • Laboratories Performing DNA Sequencing by Market Segment
  • U.K.
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • U.K.
  • Molecular Diagnostics Test Volume by Major Application
  • U.K.
  • Major Infectious Disease Test Volume by Assay
  • U.K.
  • Major Infectious Disease Test Volume by Method
  • U.K.
  • Molecular Diagnostics Market by Major Application
  • U.K.
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • U.K.
  • Major Infectious Disease Diagnostics Market by Assay
  • U.K.
  • AIDS Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • U.K.
  • HIV/Hepatitis Blood Screening NAT Market
  • Reagent Sales by Major Supplier
  • U.K.
  • Influenza Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Pneumonia Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Shigella Testing Market Estimated Sales by Major Supplier
  • Major Companies Developing or Marketing AIDS Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Bartonella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Candida
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Clostridium
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Coronavirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Cryptosporidium
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Echovirus Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Enterovirus Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Giardia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Hantavirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Helicobacter
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Influenza
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme
  • Disease Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Measles
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Meningitis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mononucleosis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mumps
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing RSV
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Rotavirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Rubella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Septicemia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Syphilis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Trichomonas
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Oncogenes Potential Application in Cancer Diagnosis
  • Major Companies Developing or Marketing Cancer
  • Molecular Diagnostic Tests
  • Major Companies Developing or Marketing Molecular
  • Diagnostic Tests for Genetic Diseases
Back to Top